The Europe Craniomaxillofacial Devices Market would witness market growth of 9.7% CAGR during the forecast period (2022-2028).
In the field of craniomaxillofacial surgery, the DO approach is most often used. Due to the fact that DO has been the subject of a number of clinical and experimental research, the surgical method that is involved has been refined. Because of the advancements that have been made in modern orthodontics and craniomaxillofacial surgery, a growing number of patients who suffer from dentomaxillofacial abnormalities are opting to rectify their conditions via orthodontic surgery.
Orthognathic surgery is a subspecialty of plastic surgery that is notable for the length of time it takes to perform the procedure as well as the level of intricacy it entails. The blood supply to the maxillofacial region is highly rich. It is easy for there to be a reduction in clinical benefits if there is too much blood loss. Surgeons and anesthesiologists have always struggled with the challenging challenge of minimizing the risk of life-threatening bleeding complications during surgical procedures.
The market for dental equipment in Germany is the biggest in all of Europe, with a value of 2.48 billion USD in 2019. In the year 2020, the total value of dental equipment exported by the United States to Germany was 126 million USD, and the total value of dental laboratory items exported by the United States was 55.2 million USD. These figures include dental bone grafts and replacements. The market for craniomaxillofacial will see expansion as a consequence of the increasing frequency of dental problems in the area, as well as the supporting efforts of the government for growing the medical devices industry.
The Germany market dominated the Europe Craniomaxillofacial Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $120.1 million by 2028. The UK market is anticipated to grow at a CAGR of 8.8% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 10.5% during (2022 - 2028).
Based on Material, the market is segmented into Metal, Bio Absorbable, Ceramics, and Total. Based on Application, the market is segmented into Orthognathic & Dental Surgery, Neurosurgery & ENT, and Plastic Surgery. Based on Product, the market is segmented into CMF Plate & Screw Fixation, Cranial Flap Fixation, CMF Distraction, Temporomandibular Joint, Replacement, Thoracic Fixation, and Bone Graft Substitute. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Craniomaxillofacial Devices Market will Hit $2.9 Billion by 2028, at a CAGR of 9.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Johnson & Johnson (DePuy Synthes), Medtronic PLC, B. Braun Melsungen AG, Renishaw PLC, Medartis AG, Zimmer Biomet Holdings, Inc., Xilloc Medical B.V, Synimed, and KLS Martin Group.
By Material
By Application
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 